Therapeutic area

Vascular disorders – page 68

837 clinical trials
354 recruiting
378 conditions
28 countries

Clinical trials in Vascular disorders

837 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

837 clinical trials

Aortic stenosis

Not recruiting

Registered drug

Study on Protamine Sulfate and Sodium Chloride to Reduce Bleeding in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Protamine Sulfate
Sponsor:St Antonius Hospital

Contact Research Centre

Embolism venous

Not recruiting

Registered drugNo placebo

Study Comparing Bleeding Risk of Rivaroxaban and Apixaban in Patients with Acute Venous Thromboembolism

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Royal College Of Surgeons In Ireland

Contact Research Centre

Peritonitis+3

Not recruiting

Registered drugNo placebo

Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Alanine
Sponsor:Region Hovedstaden

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Janssen Cilag International

Contact Research Centre

Prinzmetal angina

Not recruiting

Registered drug

Study on the Effects of Vericiguat on Patients with Vasospastic Angina

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Insulin Aspart
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Cardiac failure+1

Not recruiting

Investigational

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Azd3427
Sponsor:AstraZeneca AB

Contact Research Centre

Ischaemic stroke

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Tenecteplase
Sponsor:Insel Gruppe AG

Contact Research Centre

Patent ductus arteriosus

Not recruiting

Registered drug

Study on the Use of Ibuprofen and Paracetamol for Treating Patent Ductus Arteriosus in Extremely Premature Infants

Registered drug

Ireland

Participants:0–17 years
Substances:Ibuprofen
Sponsor:Royal College Of Surgeons In Ireland

Contact Research Centre

Atypical haemolytic uraemic syndrome+1

Not recruiting

Registered drugNo placebo

Study on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Ravulizumab
Sponsor:Alexion Pharmaceuticals Inc.

Contact Research Centre

Cerebrovascular accident+1

Not recruiting

Registered drugNo placebo

Study on Brain Inflammation in Stroke Patients Using Ficolin-2, Gadoteric Acid, and 18F-DPA-714

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Gadoteric Acid
Sponsor:Hospices Civils De Lyon

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Study to Determine Safe Doses of Selexipag for Children with Pulmonary Arterial Hypertension

InvestigationalNo placebo

France

Participants:0–17 years
Substances:Selexipag
Sponsor:Actelion Pharmaceuticals Ltd.

Contact Research Centre

Orthostatic hypotension

Not recruiting

Registered drug

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Ampreloxetine
Sponsor:Theravance Biopharma Ireland Limited

Contact Research Centre

Substances studied in this area

The therapies tested most often in Vascular disorders trials.

Acetylsalicylic Acid59 clinical trials Sodium Chloride55 clinical trials Clopidogrel33 clinical trials Apixaban28 clinical trials Ticagrelor28 clinical trials Rivaroxaban21 clinical trials Atorvastatin17 clinical trials Prasugrel17 clinical trials Rituximab16 clinical trials

Vascular disorders – page 68

Conditions in this area

Clinical trials in Vascular disorders

837 clinical trials

Aortic stenosis

Study on Protamine Sulfate and Sodium Chloride to Reduce Bleeding in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Embolism venous

Study Comparing Bleeding Risk of Rivaroxaban and Apixaban in Patients with Acute Venous Thromboembolism

Peritonitis+3

Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Prinzmetal angina

Study on the Effects of Vericiguat on Patients with Vasospastic Angina

Cardiac failure+1

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Ischaemic stroke

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Patent ductus arteriosus

Study on the Use of Ibuprofen and Paracetamol for Treating Patent Ductus Arteriosus in Extremely Premature Infants

Atypical haemolytic uraemic syndrome+1

Study on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome

Cerebrovascular accident+1

Study on Brain Inflammation in Stroke Patients Using Ficolin-2, Gadoteric Acid, and 18F-DPA-714

Pulmonary arterial hypertension

Study to Determine Safe Doses of Selexipag for Children with Pulmonary Arterial Hypertension

Orthostatic hypotension

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.